Weight loss drugs Ozempic and Wegovy would no longer be covered by California's health insurance for low-income people under ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their ...

Eli Lilly's tirzepatide leads to 50% more weight loss compared to Novo Nordisk's semaglutide in 72-week study.

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.